Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingqin Ma

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Journal of Gastrointestinal Oncology|March 14, 2024
Regional delivery of mesothelin-targeted chimeric antigen receptor T-cell effectively and safely targets colorectal cancer liver metastases in miceXin Zhou, Minjie Yang, Jiaze Yu, et al.
Clinics and Research in Hepatology and Gastroenterology|June 30, 2022
Microwave ablation combined with lipiodol-microsphere mixed or conventional transarterial chemoembolization for the treatment of colorectal liver metastases: A retrospective studyQin Shi, Feihang Wang, Nan Du, et al.
Hepatology International|March 5, 2026
A noninvasive model for predicting intrahepatic venovenous shunts before HVPG measurement: a multiple cohort studyRufeng Chen, Li Ma, Yaozu Liu, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 22, 2024
Fine-Needle Portosystemic Pressure Gradient as a Reference for Portal Hypertension in Patients with Intrahepatic Venovenous Shunt: A Prospective StudyLi Ma, Ying Fang, Wen Zhang, et al.
Radiologie (Heidelberg, Germany)|February 21, 2024
CBCT-based three-dimensional dual-phase vascular image fusion: a novel technique for interventional real-time TIPS guidanceHuibin Shi, Zhiquan Zhuang, Suming Zhang, et al.
Research (Washington, D.C.)|January 29, 2026
Transarterial Chemoembolization Modulates the Exosomal miR-32-5p/cGAS-STING Axis Mediated Macrophage Ferroptosis, Triggers Immune Remodeling, and Enhances Anti-PD-1/L1 Efficacy in HCCBufu Tang, Dandan Guo, Weiliang Hou, et al.
Biomaterials|January 25, 2024
Hypoxia-activated cascade nanovaccine for synergistic chemoembolization-immune therapy of hepatocellular carcinomaQin Shi, Wen Zhang, Yongjie Zhou, et al.
Molecular Cancer|April 10, 2026
Ferroptosis as a therapeutic target in cancer: mechanisms, immune interactions, and emerging strategiesBufu Tang, Yaling Lin, Songhua Cai, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of Gastrointestinal Oncology|March 14, 2024
Regional delivery of mesothelin-targeted chimeric antigen receptor T-cell effectively and safely targets colorectal cancer liver metastases in miceXin Zhou, Minjie Yang, Jiaze Yu, et al.
Clinics and Research in Hepatology and Gastroenterology|June 30, 2022
Microwave ablation combined with lipiodol-microsphere mixed or conventional transarterial chemoembolization for the treatment of colorectal liver metastases: A retrospective studyQin Shi, Feihang Wang, Nan Du, et al.
Hepatology International|March 5, 2026
A noninvasive model for predicting intrahepatic venovenous shunts before HVPG measurement: a multiple cohort studyRufeng Chen, Li Ma, Yaozu Liu, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 22, 2024
Fine-Needle Portosystemic Pressure Gradient as a Reference for Portal Hypertension in Patients with Intrahepatic Venovenous Shunt: A Prospective StudyLi Ma, Ying Fang, Wen Zhang, et al.
Radiologie (Heidelberg, Germany)|February 21, 2024
CBCT-based three-dimensional dual-phase vascular image fusion: a novel technique for interventional real-time TIPS guidanceHuibin Shi, Zhiquan Zhuang, Suming Zhang, et al.
Research (Washington, D.C.)|January 29, 2026
Transarterial Chemoembolization Modulates the Exosomal miR-32-5p/cGAS-STING Axis Mediated Macrophage Ferroptosis, Triggers Immune Remodeling, and Enhances Anti-PD-1/L1 Efficacy in HCCBufu Tang, Dandan Guo, Weiliang Hou, et al.
Biomaterials|January 25, 2024
Hypoxia-activated cascade nanovaccine for synergistic chemoembolization-immune therapy of hepatocellular carcinomaQin Shi, Wen Zhang, Yongjie Zhou, et al.
Molecular Cancer|April 10, 2026
Ferroptosis as a therapeutic target in cancer: mechanisms, immune interactions, and emerging strategiesBufu Tang, Yaling Lin, Songhua Cai, et al.
Pageof 5